{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:19:23Z","timestamp":1789604363433,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.tem.2023.10.005","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T08:33:03Z","timestamp":1699432383000},"page":"151-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9640-6213","authenticated-orcid":false,"given":"Laia","family":"Gomez-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-9143","authenticated-orcid":false,"given":"Juan","family":"Dominguez-Bendala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3326-3185","authenticated-orcid":false,"given":"Ricardo L.","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-0779","authenticated-orcid":false,"given":"Marta","family":"Vives-Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2023.10.005_bb0005","first-page":"1360","article-title":"Type I diabetes mellitus","volume":"314","author":"Eisenbarth","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.10.005_bb0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2023.10.005_bb0015","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2023.10.005_bb0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/pedi.12597","article-title":"Genetics of type 1 diabetes","volume":"19","author":"Redondo","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2337\/dc18-0288","article-title":"Identical and nonidentical twins: risk and factors involved in development of islet autoimmunity and type 1 diabetes","volume":"42","author":"Triolo","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.10.005_bb0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrendo.2016.30","article-title":"Viral infections in type 1 diabetes mellitus \u2014 why the \u03b2 cells?","volume":"12","author":"De Beeck","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2023.10.005_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41574-022-00688-1","article-title":"Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus","volume":"18","author":"Pandoua Nekoua","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2023.10.005_bb0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jcjd.2016.05.002","article-title":"Environmental risk factors and type 1 diabetes: past, present, and future","volume":"40","author":"Butalia","year":"2016","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0045","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1126\/sciimmunol.aao4013","article-title":"Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors","volume":"3","author":"Culina","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tem.2023.10.005_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/pedi.12734","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: stages of type 1 diabetes in children and adolescents","volume":"19","author":"Couper","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.16","article-title":"(2017) Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tem.2023.10.005_bb0065","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00125-019-4822-4","article-title":"Beta cells in type 1 diabetes: mass and function; sleeping or dead?","volume":"62","author":"Oram","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.10.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143683","article-title":"A little help from residual \u03b2 cells has long-lasting clinical benefits","volume":"131","author":"Lam","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2023.10.005_bb0075","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1007\/s00125-010-1817-6","article-title":"Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes","volume":"53","author":"Willcox","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.10.005_bb0080","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nri2192","article-title":"Type 1 diabetes as a relapsing\u2013remitting disease?","volume":"7","author":"von Herrath","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-543X.2006.00155.x","article-title":"\u2018The honeymoon phase\u2019 in children with type 1 diabetes mellitus: Frequency, duration, and influential factors","volume":"7","author":"Abdul-Rasoul","year":"2006","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0090","first-page":"332","article-title":"Stabilization of the diabetic child","volume":"59","author":"Jackson","year":"1940","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.tem.2023.10.005_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1399-5448.2007.00272.x","article-title":"Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data","volume":"9","author":"Brown","year":"2008","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3207","article-title":"The remission phase in type 1 diabetes: changing epidemiology, definitions, and emerging immuno-metabolic mechanisms","volume":"36","author":"Zhong","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.tem.2023.10.005_bb0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MED.0b013e32832e0693","article-title":"The honeymoon phase: intersection of metabolism and immunology","volume":"16","author":"Aly","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.tem.2023.10.005_bb0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000479030","article-title":"Remission phase in paediatric type 1 diabetes: new understanding and emerging biomarkers","volume":"88","author":"Fonolleda","year":"2017","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.tem.2023.10.005_bb0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.6065\/apem.2040202.101","article-title":"Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission","volume":"26","author":"Wong","year":"2021","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.10.005_bb0120","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/pedi.12413","article-title":"Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria","volume":"18","author":"Nagl","year":"2017","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0125","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/dmrr.600","article-title":"Immunological mechanisms associated with long-term remission of human type 1 diabetes","volume":"22","author":"Karges","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.tem.2023.10.005_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/pedi.12773","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents","volume":"19","author":"Mayer-Davis","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0135","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc08-1987","article-title":"New definition for the partial remission period in children and adolescents with type 1 diabetes","volume":"32","author":"Mortensen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.10.005_bb0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/pedi.12208","article-title":"Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes","volume":"15","author":"Max Andersen","year":"2014","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.884219","article-title":"Partial clinical remission of type 1 diabetes: the need for an integrated functional definition based on insulin-dose adjusted A1c and insulin sensitivity score","volume":"13","author":"Nwosu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2023.10.005_bb0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/pedi.12808","article-title":"An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes","volume":"20","author":"Buchanan","year":"2019","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0155","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3389\/fendo.2019.00824","article-title":"The remission phase in type 1 diabetes: role of hyperglycemia rectification in immune modulation","volume":"10","author":"Tang","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2023.10.005_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-34037-7","article-title":"Complete remission in children and adolescents with type 1 diabetes mellitus\u2014prevalence and factors","volume":"13","author":"Podolakova","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2023.10.005_bb0165","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.3390\/ijerph17134801","article-title":"Influence of age on partial clinical remission among children with newly diagnosed type 1 diabetes","volume":"17","author":"Passanisi","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.tem.2023.10.005_bb0170","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/dme.13439","article-title":"Exercise to preserve \u03b2-cell function in recent-onset Type 1 diabetes mellitus (EXTOD) \u2013 a randomized controlled pilot trial","volume":"34","author":"Narendran","year":"2017","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2023.10.005_bb0175","first-page":"17","article-title":"Immunoregulatory biomarkers of the remission phase in type 1 diabetes: miR-30d-5p Modulates PD-1 expression and regulatory T cell expansion","volume":"9","author":"Gomez-Mu\u00f1oz","year":"2023","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.tem.2023.10.005_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.825426","article-title":"Candidate biomarkers for the prediction and monitoring of partial remission in pediatric type 1 diabetes","volume":"13","author":"Gomez-Mu\u00f1oz","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.611522","article-title":"NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes","volume":"11","author":"Gomez-Mu\u00f1oz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0190","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/pedi.12671","article-title":"Immune cell and cytokine patterns in children with type 1 diabetes mellitus undergoing a remission phase: a longitudinal study","volume":"19","author":"Fitas","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0195","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1210\/clinem\/dgaa130","article-title":"PD-1 and PD-L1 expression in peripheral CD4\/CD8+ T cells is restored in the partial remission phase in type 1 diabetes","volume":"105","author":"Li","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.10.005_bb0200","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/js.2019-00016","article-title":"Pubertal lipid levels are significantly lower in youth with type 1 diabetes who experienced partial clinical remission","volume":"3","author":"Nwosu","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.tem.2023.10.005_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3461","article-title":"Three-phasic pattern of C-peptide decline in type 1 diabetes patients with partial remission","volume":"37","author":"Shi","year":"2021","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.tem.2023.10.005_bb0210","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.2337\/dc21-2543","article-title":"Glycemic variability patterns strongly correlate with partial remission status in children with newly diagnosed type 1 diabetes","volume":"45","author":"Poll\u00e9","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.10.005_bb0215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.trsl.2019.03.002","article-title":"Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. a pilot study","volume":"210","author":"Villalba","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.tem.2023.10.005_bb0220","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fendo.2021.705565","article-title":"Partial clinical remission reduces lipid-based cardiovascular risk in adult patients with type 1 diabetes","volume":"12","author":"Nwosu","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2023.10.005_bb0225","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2630827","article-title":"The association of autoimmune diseases with type 1 diabetes mellitus in children depends also by the length of partial clinical remission phase (honeymoon)","volume":"2020","author":"Ozen","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.tem.2023.10.005_bb0230","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1515\/jpem-2020-0220","article-title":"Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes","volume":"33","author":"Nwosu","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.10.005_bb0235","first-page":"11","article-title":"Sustained spontaneous partial remission in a pediatric patient with type 1 diabetes","volume":"6","author":"Murillo","year":"2017","journal-title":"J. Clin. Transl. Endocrinol. Case Rep."},{"key":"10.1016\/j.tem.2023.10.005_bb0240","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2337\/diacare.27.5.1207","article-title":"Complete long-term recovery of \u03b2-cell function in autoimmune type 1 diabetes after insulin treatment","volume":"27","author":"Karges","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2023.10.005_bb0245","doi-asserted-by":"crossref","first-page":"28709","DOI":"10.3402\/jchimp.v5.28709","article-title":"Spontaneous complete remission of type 1 diabetes mellitus in an adult \u2013 review and case report","volume":"5","author":"Moole","year":"2015","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"10.1016\/j.tem.2023.10.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093326","article-title":"Predictive models of type 1 diabetes progression: understanding T-cell cycles and their implications on autoantibody release","volume":"9","author":"Jaberi-Douraki","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2023.10.005_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104625","article-title":"Gene expression signature predicts rate of type 1 diabetes progression","volume":"92","author":"Suomi","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2023.10.005_bb0260","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/db20-0817","article-title":"Baseline assessment of circulating microRNAs near diagnosis of type 1 diabetes predicts future stimulated insulin secretion","volume":"70","author":"Snowhite","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0265","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/1753-0407.13044","article-title":"Frequency, clinical characteristics, and determinants of partial remission in type 1 diabetes: Different patterns in children and adults","volume":"12","author":"Zhong","year":"2020","journal-title":"J. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176860","article-title":"A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes","volume":"12","author":"Marino","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2023.10.005_bb0275","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/pedi.12824","article-title":"Remission phase in children diagnosed with type 1 diabetes in years 2012 to 2013 in Silesia, Poland: an observational study","volume":"20","author":"Chobot","year":"2019","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0280","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00125-022-05837-9","article-title":"Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes","volume":"66","author":"Coomans de Brach\u00e8ne","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.10.005_bb0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/dme.13802","article-title":"The Type 1 diabetes \u2018honeymoon\u2019 period is five times longer in men who exercise: a case\u2013control study","volume":"36","author":"Chetan","year":"2019","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2023.10.005_bb0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.clim.2007.12.003","article-title":"Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes","volume":"127","author":"Sanda","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0295","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2337\/db07-1697","article-title":"Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes","volume":"57","author":"Pfleger","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0300","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2249.2006.03172.x","article-title":"Association of interferon-\u03b3 and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes","volume":"145","author":"Alizadeh","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0305","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136114","article-title":"CD4+CD25+CD127hi cell frequency predicts disease progression in type 1 diabetes","volume":"6","author":"Narsale","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.tem.2023.10.005_bb0310","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2016.04.012","article-title":"A pilot study showing associations between frequency of CD4+ memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes","volume":"166\u2013167","author":"Moya","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0315","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2249.2007.03475.x","article-title":"Dynamic changes in CD4+ CD25+ high T cell apoptosis after the diagnosis of type 1 diabetes","volume":"150","author":"Glisic-Milosavljevic","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0320","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s00125-018-4708-x","article-title":"Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes","volume":"61","author":"Cabrera","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.10.005_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1315","article-title":"Proinsulin-specific T-cell responses correlate with estimated c-peptide and predict partial remission duration in type 1 diabetes","volume":"10","author":"Musthaffa","year":"2021","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.tem.2023.10.005_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958430","article-title":"Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children","volume":"13","author":"Starosz","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0335","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00125-017-4377-1","article-title":"Regulatory T cell dysfunction in type 1 diabetes: what\u2019s broken and how can we fix it?","volume":"60","author":"Hull","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.10.005_bb0340","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tem.2023.10.005_bb0345","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmet.2018.07.007","article-title":"Conventional and neo-antigenic peptides presented by \u03b2 cells are targeted by circulating na\u00efve CD8+ T cells in type 1 diabetic and healthy donors","volume":"28","author":"Gonzalez-Duque","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.10.005_bb0350","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2023.10.005_bb0355","article-title":"Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report","volume":"2016","author":"Kurozumi","year":"2016","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"10.1016\/j.tem.2023.10.005_bb0360","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/dom.14723","article-title":"Combined therapy with CD4+CD25highCD127\u2212 T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: randomized phase I\/II trial","volume":"24","author":"Zieli\u0144ski","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2023.10.005_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-021-01384-6","article-title":"The role of programmed death-1 in type 1 diabetes","volume":"21","author":"Tucker","year":"2021","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.tem.2023.10.005_bb0370","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tem.2023.10.005_bb0375","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1084\/jem.20061577","article-title":"Insulin-induced remission in new-onset NOD mice is maintained by the PD-1\u2013PD-L1 pathway","volume":"203","author":"Fife","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tem.2023.10.005_bb0380","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.2337\/db12-1475","article-title":"PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes","volume":"62","author":"Pauken","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0385","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2008.03.458","article-title":"Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes","volume":"128","author":"Pfleger","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0390","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","article-title":"Metabolic regulation of T lymphocytes","volume":"31","author":"Maciver","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0395","article-title":"Enhanced T cell glucose uptake is associated with progression of beta-cell function in type 1 diabetes","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0400","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00125-020-05107-6","article-title":"Metabolic alterations in immune cells associate with progression to type 1 diabetes","volume":"63","author":"Sen","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.10.005_bb0405","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00125-023-05938-z","article-title":"Recovery of intracellular glucose uptake in T cells during partial remission of type 1 diabetes","volume":"66","author":"Tang","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.10.005_bb0410","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41422-020-0379-5","article-title":"Metabolic signaling in T cells","volume":"30","author":"Shyer","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.tem.2023.10.005_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669456","article-title":"Glycolysis inhibition induces functional and metabolic exhaustion of CD4+ T cells in type 1 diabetes","volume":"12","author":"Martins","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0420","first-page":"16","article-title":"Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3","volume":"2016","author":"Pinheiro","year":"2016","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"10.1016\/j.tem.2023.10.005_bb0425","doi-asserted-by":"crossref","DOI":"10.20945\/2359-3997000000652","article-title":"Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study","volume":"67","author":"Pinheiro","year":"2023","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.10.005_bb0430","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejps.2016.12.040","article-title":"Sitagliptin inhibit human lymphocytes proliferation and Th1\/Th17 differentiation in vitro","volume":"100","author":"Pinheiro","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tem.2023.10.005_bb0435","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/db08-1101","article-title":"Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation","volume":"58","author":"Kim","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14702","article-title":"Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study","volume":"39","author":"M\u00f8rk","year":"2022","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2023.10.005_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.819544","article-title":"The theory of hyperlipidemic memory of type 1 diabetes","volume":"13","author":"Nwosu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2023.10.005_bb0450","article-title":"Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis","volume":"13","author":"Udoka Nwosu","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2023.10.005_bb0455","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/pedi.12421","article-title":"Effect of autoimmunity risk loci on the honeymoon phase in type 1 diabetes","volume":"18","author":"Moosavi","year":"2017","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063296","article-title":"Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity","volume":"8","author":"Pujol-Autonell","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2023.10.005_bb0465","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1210\/clinem\/dgab589","article-title":"The unfavorable impact of DR9\/DR9 genotype on the frequency and quality of partial remission in type 1 diabetes","volume":"107","author":"Chen","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2023.10.005_bb0470","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/db05-1049","article-title":"Combination of HLA-A24, -DQA1*03, and -DR9 contributes to acute-onset and early complete \u03b2-cell destruction in type 1 diabetes: longitudinal study of residual \u03b2-cell function","volume":"55","author":"Nakanishi","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2023.10.005_bb0475","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cmet.2018.09.011","article-title":"Lymphocyte-derived exosomal microRNAs promote pancreatic \u03b2 cell death and may contribute to type 1 diabetes development","volume":"29","author":"Guay","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2023.10.005_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.606322","article-title":"miRNA-mediated immune regulation in islet autoimmunity and type 1 diabetes","volume":"11","author":"Scherm","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.tem.2023.10.005_bb0485","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3389\/fimmu.2018.02381","article-title":"Serum microRNA profiles serve as novel biomarkers for autoimmune diseases","volume":"9","author":"Jin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2023.10.005_bb0490","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89656","article-title":"Profiling of circulating microRNAs in children with recent onset of type 1 diabetes","volume":"2","author":"Erener","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.tem.2023.10.005_bb0495","first-page":"35","article-title":"Influence of disease duration on circulating levels of miRNAs in children and adolescents with new onset type 1 diabetes","volume":"4","author":"Samandari","year":"2018","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.tem.2023.10.005_bb0500","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00125-020-05237-x","article-title":"Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes","volume":"63","author":"Garavelli","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2023.10.005_bb0505","doi-asserted-by":"crossref","first-page":"31155","DOI":"10.1074\/jbc.M112.362632","article-title":"MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic \u03b2-cells","volume":"287","author":"Zhao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2023.10.005_bb0510","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023002187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276023002187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:46:14Z","timestamp":1760906774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276023002187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1043276023002187"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2023.10.005","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2023.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}